US FDA-industry study warns of RFID interference risks for implantables
This article was originally published in RAJ Devices
Executive Summary
A joint US Food and Drug Administration-industry study examining the impact of radiofrequency identification systems on common implantable devices has raised concerns about electromagnetic interference1,2.